A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores - Jiang, Y; Genant, H K; Watt, I (Arthritis Rheum, 2000)
et al.